These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33940213)

  • 1. Pragmatic Randomized Controlled Trial for Stepping Down Asthma Controller Treatment in Patients Controlled with Low-Dose Inhaled Corticosteroid and Long-Acting β
    Kim SH; Lee T; Jang AS; Park CS; Jung JW; Kim MH; Kwon JW; Moon JY; Yang MS; Lee J; Choi JH; Shin YS; Kim HK; Kim S; Kim JH; Lee SY; Nam YH; Kim SH; Kim TB;
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3638-3646.e3. PubMed ID: 33940213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial.
    Rogers L; Sugar EA; Blake K; Castro M; Dimango E; Hanania NA; Happel KI; Peters SP; Reibman J; Saams J; Teague WG; Wise RA; Holbrook JT;
    J Allergy Clin Immunol Pract; 2018; 6(2):633-643.e1. PubMed ID: 28974349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy.
    Weinstein CLJ; Ryan N; Zhang X; Shekar T; Gates D; Lane SJ; Agache I; Nathan RA;
    J Allergy Clin Immunol Pract; 2020 May; 8(5):1634-1644.e1. PubMed ID: 31981733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Mori K; Fujisawa T; Inui N; Hashimoto D; Enomoto N; Nakamura Y; Kuroishi S; Yokomura K; Toyoshima M; Imokawa S; Yamada T; Shirai T; Masuda M; Hayakawa H; Chida K; Suda T
    Respir Med; 2016 Oct; 119():1-6. PubMed ID: 27692128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting β2-agonist step-off in patients with controlled asthma.
    Brozek JL; Kraft M; Krishnan JA; Cloutier MM; Lazarus SC; Li JT; Santesso N; Strunk RC; Casale TB
    Arch Intern Med; 2012 Oct; 172(18):1365-75. PubMed ID: 22928176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.
    Turner S; Richardson K; Murray C; Thomas M; Hillyer EV; Burden A; Price DB;
    J Allergy Clin Immunol Pract; 2017; 5(1):99-106.e3. PubMed ID: 27421902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β
    Devillier P; Humbert M; Boye A; Zachgo W; Jacques L; Nunn C; West S; Nicholls A; Antoun Z; Spinu L; Grouin JM
    Respir Med; 2018 Aug; 141():111-120. PubMed ID: 30053956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β
    Buhl R; Heaney LG; Loefroth E; Larbig M; Kostikas K; Conti V; Cao H
    Respir Med; 2020 Feb; 162():105859. PubMed ID: 31916534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepping down the dose of inhaled corticosteroids for adults with asthma.
    Crossingham I; Evans DJ; Halcovitch NR; Marsden PA
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011802. PubMed ID: 28146601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
    Israel E; Roche N; Martin RJ; Colice G; Dorinsky PM; Postma DS; Guilbert TW; van Aalderen WM; Grigg J; Hillyer EV; Burden A; von Ziegenweidt J; Thomas V; Price DB
    Ann Am Thorac Soc; 2015 Jun; 12(6):798-806. PubMed ID: 25756308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Haruta Y; Hozawa M
    Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.
    Chantaphakul H; Ruxrungtham K
    Expert Opin Pharmacother; 2016; 17(5):631-42. PubMed ID: 26799114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study.
    Park SY; Kim S; Kim JH; Kim SH; Lee T; Yoon SY; Kim MH; Moon JY; Yang MS; Jung JW; Kim JH; Choi JH; Park CS; Kim S; Lee J; Kwon JW; Hur GY; Kim SH; Kim HK; Shin YS; Kim SH; Nam YH; Jang AS; Park SY; Kim TB;
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1304-1311.e2. PubMed ID: 33184024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.